ATE12771T1 - 6-chloro- oder 6-bromo-1,2-dihydro-3h-pyrrolo(1,2-a)pyrrol-1-c rbonsaeuren und derivate davon, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen. - Google Patents
6-chloro- oder 6-bromo-1,2-dihydro-3h-pyrrolo(1,2-a)pyrrol-1-c rbonsaeuren und derivate davon, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen.Info
- Publication number
- ATE12771T1 ATE12771T1 AT81104368T AT81104368T ATE12771T1 AT E12771 T1 ATE12771 T1 AT E12771T1 AT 81104368 T AT81104368 T AT 81104368T AT 81104368 T AT81104368 T AT 81104368T AT E12771 T1 ATE12771 T1 AT E12771T1
- Authority
- AT
- Austria
- Prior art keywords
- bromo
- chloro
- pyrrolo
- dihydro
- rbonic
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 150000007513 acids Chemical class 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- XWQXHYYQCCZBSH-UHFFFAOYSA-N 2-bromo-6,7-dihydro-5h-pyrrolizine-1-carboxylic acid Chemical class C1CCC2=C(C(=O)O)C(Br)=CN21 XWQXHYYQCCZBSH-UHFFFAOYSA-N 0.000 abstract 1
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 abstract 1
- 125000000389 2-pyrrolyl group Chemical group [H]N1C([*])=C([H])C([H])=C1[H] 0.000 abstract 1
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 abstract 1
- 125000003682 3-furyl group Chemical group O1C([H])=C([*])C([H])=C1[H] 0.000 abstract 1
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 abstract 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 239000002221 antipyretic Substances 0.000 abstract 1
- 229940125716 antipyretic agent Drugs 0.000 abstract 1
- 125000001246 bromo group Chemical group Br* 0.000 abstract 1
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000050 smooth muscle relaxant Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/337—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/157,719 US4344943A (en) | 1980-06-09 | 1980-06-09 | 6-Chloro- or 6-bromo-1,2-dihydro-3H-pyrrolo[1,2-a]-pyrrole-1-carboxylic acids and derivatives thereof |
| EP81104368A EP0041711B1 (de) | 1980-06-09 | 1981-06-05 | 6-Chloro- oder 6-Bromo-1,2-dihydro-3H-pyrrolo(1,2-a)pyrrol-1-carbonsäuren und Derivate davon, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE12771T1 true ATE12771T1 (de) | 1985-05-15 |
Family
ID=22564979
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT81104368T ATE12771T1 (de) | 1980-06-09 | 1981-06-05 | 6-chloro- oder 6-bromo-1,2-dihydro-3h-pyrrolo(1,2-a)pyrrol-1-c rbonsaeuren und derivate davon, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4344943A (de) |
| EP (1) | EP0041711B1 (de) |
| JP (1) | JPS5714591A (de) |
| KR (1) | KR850000609B1 (de) |
| AT (1) | ATE12771T1 (de) |
| AU (1) | AU546012B2 (de) |
| CA (1) | CA1178277A (de) |
| DE (1) | DE3169956D1 (de) |
| DK (1) | DK249781A (de) |
| ES (1) | ES8203376A1 (de) |
| GR (1) | GR74615B (de) |
| HU (1) | HU185430B (de) |
| IE (1) | IE51523B1 (de) |
| IL (1) | IL63047A (de) |
| NZ (1) | NZ197331A (de) |
| PT (1) | PT73154B (de) |
| SU (1) | SU1217260A3 (de) |
| YU (2) | YU43235B (de) |
| ZA (1) | ZA813829B (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4457941A (en) * | 1982-03-22 | 1984-07-03 | Syntex (U.S.A.) Inc. | Use of pyrrolo-pyrrole in treating microvascular diseases associated with diabetes |
| US4454151A (en) * | 1982-03-22 | 1984-06-12 | Syntex (U.S.A.) Inc. | Use of pyrrolo pyrroles in treatment of ophthalmic diseases |
| US4612325A (en) * | 1982-06-08 | 1986-09-16 | Syntex (U.S.A) Inc. | 5-Aroyl-6-alkylthio-1,2-dihydro-3H-pyrrolo(1,2-A)pyrrole-1-carboxylic acids and use thereof as analgesics and anti-inflammatories |
| US4511724A (en) * | 1982-06-10 | 1985-04-16 | Merck & Co., Inc. | 5-(Pyrrol-2-oyl)-1,2-dihydro-3H-pyrrolo [1,2-a]pyrrole derivatives as anti-inflammatory and analgesic agents |
| US4849526A (en) * | 1987-01-14 | 1989-07-18 | Syntex (U.S.A.) Inc. | Process for preparing (±)-2,3-dihydro-1H-pyrrolo[1,2-A]pyrrole-1,7-dicarboxylates |
| HU198927B (en) * | 1987-01-14 | 1989-12-28 | Richter Gedeon Vegyeszet | Process for producing 1-/substituted aminomethyl/-octa-hydroindolo-(2,3-a)quinolizine derivatives, pharmaceutically applicable acid addition salts thereof, as well as pharmaceutical compositions comprising same |
| US4874872A (en) * | 1987-01-14 | 1989-10-17 | Syntex (U.S.A.) Inc. | Process for preparing (+)-2,3-dihydro-1H-pyrrolo[1,2-A]pyrrole-1,7-dicarboxylates |
| US4835288A (en) * | 1987-01-14 | 1989-05-30 | Syntex Inc. | Process for preparing (+)-2,3-dihydro-1H-pyrrolo[1,2-a]pyrrole-1,7-dicarboxylates |
| US4874871A (en) * | 1987-03-25 | 1989-10-17 | Syntex (U.S.A.) Inc. | Process for preparing (+)-2,3-Dihydro-1H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid and related compounds |
| JP2649168B2 (ja) * | 1988-02-25 | 1997-09-03 | 久光製薬株式会社 | 新規な5,6−ジフェニル−1,2−ジヒドロ−3H−ピロロ[1,2−a]ピロール−1−カルボン酸誘導体 |
| US5082950A (en) * | 1990-10-12 | 1992-01-21 | Syntex (U.S.A.) Inc. | Process for preparing 5-aroyl-2,3-dihydro-1H-pyrrolizine-1,1-dicarboxylates (II) and intermediates therefor |
| WO1995001767A1 (en) * | 1993-07-08 | 1995-01-19 | Cygnus Therapeutic Systems | Monolithic matrix transdermal delivery system |
| US5621115A (en) * | 1996-02-21 | 1997-04-15 | Ohmeda Pharmaceutical Products Division Inc. | Methods for preparing 5-aroyl-1,2-dihydro-3H-pyrrolo-[1,2-A]pyrrole-1-carboxylic acids |
| US6191285B1 (en) | 1997-07-03 | 2001-02-20 | Abbott Laboratories | Process for the preparation of ketorolac tromethamine |
| ES2449194T3 (es) * | 2000-01-19 | 2014-03-18 | Cadila Healthcare Limited | Compuestos que tienen actividades hipolipidémica e hipocolesterolémica, procedimiento para su preparación y composiciones farmacéuticas que los contienen |
| WO2002062341A1 (en) * | 2001-02-07 | 2002-08-15 | University Of Florida | Method and composition for the control of hair growth |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4089969A (en) * | 1976-07-14 | 1978-05-16 | Syntex (U.S.A.) Inc. | 5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof |
| US4087539A (en) * | 1976-07-14 | 1978-05-02 | Syntex (U.S.A.) Inc. | 5-(2-Furoyl)-, 5-(2-thenoyl)-, 5-(3-furoyl)- and 5-(3-thenoyl)-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof |
| JPS539788A (en) * | 1976-07-14 | 1978-01-28 | Syntex Inc | 55aloyll1*22dihydroo3hh pyroro *1*22a* pyroll11 carboxylic acid derivative |
| US4097579A (en) * | 1977-03-31 | 1978-06-27 | Syntex (U.S.A.) Inc. | 5-(2-Pyrroyl)-1,2-dihydro-3H-pyrrolo 1,2-a!pyrrole-1-carboxylic acid derivatives and process for the production thereof |
| US4140698A (en) * | 1977-07-25 | 1979-02-20 | Syntex (Usa) Inc. | 1,2-Dihydro-3H-pyrrolo[1,2-a]pyrrole-1-nitriles |
| US4232038A (en) * | 1979-08-31 | 1980-11-04 | Syntex (U.S.A.) Inc. | 5-Alkylsulfinylbenzoyl- and 5-alkylsulfonylbenzoyl-1,2-dihydro-3H-pyrrolo[1,]pyrrole-1-carboxylic acids |
-
1980
- 1980-06-09 US US06/157,719 patent/US4344943A/en not_active Expired - Lifetime
-
1981
- 1981-04-02 JP JP4999181A patent/JPS5714591A/ja active Pending
- 1981-06-03 KR KR1019810001987A patent/KR850000609B1/ko not_active Expired
- 1981-06-04 DK DK249781A patent/DK249781A/da not_active Application Discontinuation
- 1981-06-05 AT AT81104368T patent/ATE12771T1/de not_active IP Right Cessation
- 1981-06-05 EP EP81104368A patent/EP0041711B1/de not_active Expired
- 1981-06-05 YU YU1423/81A patent/YU43235B/xx unknown
- 1981-06-05 DE DE8181104368T patent/DE3169956D1/de not_active Expired
- 1981-06-05 IL IL63047A patent/IL63047A/xx unknown
- 1981-06-08 IE IE1269/81A patent/IE51523B1/en unknown
- 1981-06-08 CA CA000379266A patent/CA1178277A/en not_active Expired
- 1981-06-08 GR GR65174A patent/GR74615B/el unknown
- 1981-06-08 ZA ZA00813829A patent/ZA813829B/xx unknown
- 1981-06-08 SU SU813300100A patent/SU1217260A3/ru active
- 1981-06-08 NZ NZ197331A patent/NZ197331A/en unknown
- 1981-06-08 HU HU811700A patent/HU185430B/hu not_active IP Right Cessation
- 1981-06-08 PT PT73154A patent/PT73154B/pt unknown
- 1981-06-08 ES ES502855A patent/ES8203376A1/es not_active Expired
- 1981-06-09 AU AU71438/81A patent/AU546012B2/en not_active Ceased
-
1983
- 1983-06-22 YU YU01370/83A patent/YU137083A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GR74615B (de) | 1984-06-29 |
| IL63047A0 (en) | 1981-09-13 |
| DK249781A (da) | 1981-12-10 |
| NZ197331A (en) | 1985-05-31 |
| ES502855A0 (es) | 1982-04-01 |
| YU43235B (en) | 1989-06-30 |
| PT73154A (en) | 1981-07-01 |
| IE811269L (en) | 1981-12-09 |
| CA1178277A (en) | 1984-11-20 |
| KR830006289A (ko) | 1983-09-20 |
| DE3169956D1 (en) | 1985-05-23 |
| KR850000609B1 (ko) | 1985-05-01 |
| AU546012B2 (en) | 1985-08-08 |
| IE51523B1 (en) | 1987-01-07 |
| SU1217260A3 (ru) | 1986-03-07 |
| ZA813829B (en) | 1983-01-26 |
| EP0041711B1 (de) | 1985-04-17 |
| HU185430B (en) | 1985-02-28 |
| ES8203376A1 (es) | 1982-04-01 |
| PT73154B (en) | 1982-07-16 |
| IL63047A (en) | 1984-07-31 |
| JPS5714591A (en) | 1982-01-25 |
| YU142381A (en) | 1983-12-31 |
| AU7143881A (en) | 1981-12-17 |
| YU137083A (en) | 1983-12-31 |
| US4344943A (en) | 1982-08-17 |
| EP0041711A1 (de) | 1981-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE12771T1 (de) | 6-chloro- oder 6-bromo-1,2-dihydro-3h-pyrrolo(1,2-a)pyrrol-1-c rbonsaeuren und derivate davon, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen. | |
| ATE4903T1 (de) | 1-, 6- und 2-substituierte 1-carba-2-penem-3carbons[ure, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
| DE69030206D1 (de) | Pyrazolopyridinverbindungen und Verfahren zu ihrer Herstellung | |
| IE780605L (en) | 1, 2-DIHYDRO-3H-PYRROLO [1,2-a] PYRROLES | |
| AR010984A1 (es) | Nuevos esteres de la pleuromutilina, y el acido 1-azabiciclo-4- carbanilcarbanico; procedimiento para su preparacion y composicionesfarmaceuticas que los contienen. | |
| ATE25679T1 (de) | Isochinolinderivate, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung. | |
| IE45051L (en) | Quinazolines | |
| IE780403L (en) | Antiphlogistic compositions | |
| SE7902915L (sv) | 4-oxo-4h-pyrido(1,2-a)pyrimidin-3-n-(1h-tetrazol-5-yl) karboxamidderivat och deras anvendning sasom inhibitorer av allergiska reaktioner | |
| ATE7224T1 (de) | Propanolamin-derivate, ihre salze, verfahren zu ihrer herstellung und pharmazeutische praeparate. | |
| DE3262732D1 (en) | Anthranilic acids substituted by basic groups, process for their preparation and their use | |
| EP0049999A3 (de) | Cyclische Verbindungen, ihre Herstellung und ihre Verwendung | |
| PT70656A (de) | Neue linksdrehende bicyclische thia-diaza-verbindung verfahren zu ihrer herstellung diese enthaltende pharmazeutische praparate und ihre verwendung | |
| FI911616A0 (fi) | Substituerade 3-tia- eller 3-oxa-alkyl -flavoner, foerfarande foer deras framstaellning, deras anvaendning, pao dessa foereningar baserade laekemedel samt mellanprodukter. | |
| PT73789B (de) | Neue cephalosporine verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
| ATE13061T1 (de) | Neue 6alpha-methoxy-penicilline, ihre salze, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel. | |
| DK22983A (da) | Fremgangsmaade til fremstilling af penicillinderivater | |
| IE43848L (en) | Pharmaceutical compositions | |
| DE69403606D1 (de) | Cyclizierte Analoge der Fettsäurenmetaboliten, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |